Antipsychotic drug-induced movement disorders

被引:33
作者
Blanchet, PJ
机构
[1] CHUM, Hotel Dieu, Andre Barbeau Movements Disorders Unit, Montreal, PQ H2W 1T8, Canada
[2] Univ Montreal, Fac Dent, Dept Stomatol, Montreal, PQ, Canada
关键词
D O I
10.1017/S0317167100003309
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Very early in the process of diagnosing abnormal involuntary movement (AIM) disorders, one can be rewarded by keeping a high index of suspicion for possible drug-induced causes, not only through a complete list of current medications, but also identification of the drugs the patient used to take and other possible offending medications that might be available from family members and other sources. Among drug-induced movement disorders, antipsychotic drugs and other dopamine receptor blocking agents occupy a central place. Their various acute and tardive motor complications provide the template of this short review. Movement disorders caused by antidepressants, lithium, antiemetics, antiparkinsonian agents, anticonvulsants, calcium channel blockers, sympathomimetics and others are only briefly covered in table form.
引用
收藏
页码:S101 / S107
页数:7
相关论文
共 53 条
  • [31] THE PHARMACOKINETICS OF TETRABENAZINE AND ITS HYDROXY METABOLITE IN PATIENTS TREATED FOR INVOLUNTARY MOVEMENT-DISORDERS
    ROBERTS, MS
    MCLEAN, S
    MILLINGEN, KS
    GALLOWAY, HM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) : 703 - 708
  • [32] SACHDEV P, 1994, ARCH GEN PSYCHIAT, V51, P963
  • [33] Induction of reactive oxygen species in neurons by haloperidol
    Sagara, Y
    [J]. JOURNAL OF NEUROCHEMISTRY, 1998, 71 (03) : 1002 - 1012
  • [34] Sakai K, 2001, SYNAPSE, V39, P152, DOI 10.1002/1098-2396(200102)39:2<152::AID-SYN6>3.0.CO
  • [35] 2-F
  • [36] Sethi K D, 1990, J Neuropsychiatry Clin Neurosci, V2, P64
  • [37] SETHY VH, 1974, RES COMMUN CHEM PATH, V8, P13
  • [38] Melatonin treatment for tardive dyskinesia - A double-blind, placebo-controlled, crossover study
    Shamir, E
    Barak, Y
    Shalman, I
    Laudon, M
    Zisapel, N
    Tarrasch, R
    Elizur, A
    Weizman, R
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (11) : 1049 - 1052
  • [39] SILVER H, 1995, J CLIN PSYCHIAT, V56, P167
  • [40] ACUTE DYSTONIA DURING FIXED-DOSE NEUROLEPTIC TREATMENT
    SINGH, H
    LEVINSON, DF
    SIMPSON, GM
    LO, ES
    FRIEDMAN, E
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1990, 10 (06) : 389 - 396